Live Breaking News & Updates on Vascular Access Society Congress

Stay updated with breaking news from Vascular access society congress. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Outstanding 12-Month First-In-Human Data From Xeltis' Axess Hemodialysis Vascular Conduit Trial Presented At Veithsymposium 2023

Outstanding 12-Month First-In-Human Data From Xeltis' Axess Hemodialysis Vascular Conduit Trial Presented At Veithsymposium 2023
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Porto , Portugal , Belgium , Latvia , Kurma , Ludzas-novads , Italy , New-york , United-states , Lithuania , Netherlands , Utrecht

Outstanding 12-month first-in-human data from Xeltis' aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023

Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023 aXess demonstrated exceptional patency rates and no infections to date EINDHOVEN, The Netherlands – 17 November 2023, Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces outstanding 12-month data from its first-in-human (FIH) aXess vascular conduit trial (NCT04898153). The data was presen ....

Utrecht , Netherlands , United-states , Kurma , Ludzas-novads , Latvia , New-york , Lithuania , Belgium , Italy , Portugal , Porto

Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress

Xeltis presents excellent six-month first-in-human data from aXess hemodialysis vascular graft trial at Vascular Access Society Congress aXess graft demonstrated excellent patency ....

Portugal , United-states , Porto , Italy , Netherlands , Amber-fennell-chris-welsh , Eliane-schutte , Matteo-tozzi , Alexander-goemans , Davita-venture-group , Consilium-strategic-communications , Vascular-access-society-congress